"BECAUSE CANCER DOESN’T
WORK IN ONE WAY
– NEITHER SHOULD WE" - ICFBC Founder
At ICFBC, we pursue the science of integrative cancer treatments with the wisdom of clinical experience to innovate and elevate the discussion, education and all round treatment of Cancer.
Giving people with all stages and types of cancer better health, vitality and – most importantly – all the information required to make informed decisions. Learn about the different cancer treatment therapies available.
ONCOLOGY ASSOCIATION OF NATUROPATHIC PHYSICIANS: PRINCIPLES OF CARE GUIDELINES
Full POC Guidelines published by the OncANP in Current Oncology:
Companion editorial in Current Oncology – by Dr. Seely, ND and Dr. Verma, MD
LEARN ABOUT ADVANCED INTEGRATIVE CANCER THERAPIES
The Oncotherm EHY-2000 Plus medical device is a non-invasive complementary cancer treatment developed in Germany, approved by Health Canada and intended for use with chemotherapy and radiation. Hyperthermia has direct cancer-killing effects, sensitizes malignant cells to radiation and chemo, augments targeted agents and engages the immune system to fight the disease.
HIGH DOSE ASCORBIC ACID / VITAMIN C
High-Dose Ascorbic Acid is a pro-oxidative treatment with demonstrated safety and effectiveness with and without chemotherapy, supported by evidence from clinical trials. High-Dose Ascorbic Acid reduces inflammation, has direct cancer-killing effects and chemo-sensitizing effects.
DCA is a novel metabolic therapy that targets the energy-utilization of cancer cells, forcing death of the cancer cells (apopotosis). Used strategically with a low-glycemic diet and other supportive agents, DCA is a powerful tool in the treatment of advanced and metastic disease.
EUROPEAN VISCUM ALBUM EXTRACT (VAE)
Several clinical studies have shown that VAE, also known as mistletoe lectins therapy, safely improves the tolerability of chemo and radiation, while supporting the immune system during treatment. Patients using VAE also report less fatigue, better sleep and appetite.
MORE CANCER THERAPIES
Intravenous Alpha Lipoic Acid (IV ALA)